Literature DB >> 16364465

Rottlerin inhibits stimulated enzymatic secretion and several intracellular signaling transduction pathways in pancreatic acinar cells by a non-PKC-delta-dependent mechanism.

J A Tapia1, R T Jensen, L J García-Marín.   

Abstract

Protein kinase C-delta (PKC-delta) becomes activated in pancreatic acini in response to cholecystokinin (CCK) and plays a pivotal role in the exocrine pancreatic secretion. Rottlerin, a polyphenolic compound, has been widely used as a potent and specific PKC-delta inhibitor. However, some recent studies showed that rottlerin was not effective in inhibiting PKCdelta activity in vitro and that may display unspecific effects. The aims of this work were to investigate the specificity of rottlerin as an inhibitor of PKC-delta activity in intact cells and to elucidate the biochemical causes of its unspecificity. Preincubation of pancreatic acini with rottlerin (6 microM) inhibited CCK-stimulated translocation, tyrosine phosphorylation (TyrP) and activation of PKC-delta in pancreatic acini in a time-dependent manner. Rottlerin inhibited amylase secretion stimulated by both PKC-dependent pathways (CCK, bombesin, carbachol, TPA) and also by PKC-independent pathways (secretin, VIP, cAMP analogue). CCK-stimulation of MAPK activation and p125(FAK) TyrP which are mediated by PKC-dependent and -independent pathways were also inhibited by rottlerin. Moreover, rottlerin rapidly depleted ATP content in pancreatic acini in a similar way as the mitochondrial uncouplers CCCP and FCCP. All studied inhibitory effects of rottlerin in pancreatic acini were mimicked by FCCP (agonists-stimulated amylase secretion, p125(FAK) TyrP, MAPK activation and PKC-delta TyrP and translocation). Finally, rottlerin as well as FCCP display a potent inhibitory effect on the activation of other PKC isoforms present in pancreatic acini. Our results suggest that rottlerin effects in pancreatic acini are not due to a specific PKC-delta blockade, but likely due to its negative effect on acini energy resulting in ATP depletion. Therefore, to study the role of PKC-delta in cellular processes using rottlerin it is essential to keep in mind that may deplete ATP levels and inhibit different PKC isoforms. Our results give reasons for a more careful choice of rottlerin for PKC-delta investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364465     DOI: 10.1016/j.bbamcr.2005.10.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  The pathophysiologic role of the protein kinase Cδ pathway in the intervertebral discs of rabbits and mice: in vitro, ex vivo, and in vivo studies.

Authors:  Michael B Ellman; Jae-Sung Kim; Howard S An; Jeffrey S Kroin; Xin Li; Di Chen; Dongyao Yan; Doug D Buechter; Keiichi Nakayama; Bo Liu; Stephanie Morgan; Hee-Jeong Im
Journal:  Arthritis Rheum       Date:  2011-12-12

2.  Cholinergic signaling inhibits oxalate transport by human intestinal T84 cells.

Authors:  Hatim A Hassan; Ming Cheng; Peter S Aronson
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-28       Impact factor: 4.249

3.  Protein kinase C[delta] differentially regulates platelet functional responses.

Authors:  Ramya Chari; Todd Getz; Bela Nagy; Kamala Bhavaraju; Yingying Mao; Yamini Saraswathy Bynagari; Swaminathan Murugappan; Keiko Nakayama; Satya P Kunapuli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-12       Impact factor: 8.311

4.  PKCθ activation in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors is needed for stimulation of numerous important cellular signaling cascades.

Authors:  Veronica Sancho; Marc J Berna; Michelle Thill; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2011-07-23

5.  PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment.

Authors:  Eun-Joo Shin; Chu Xuan Duong; Xuan-Khanh Thi Nguyen; Guoying Bing; Jae-Hyung Bach; Dae Hun Park; Keiichi Nakayama; Syed F Ali; Anumantha G Kanthasamy; Jean L Cadet; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2011-06-13       Impact factor: 3.921

Review 6.  Protein kinase C isoforms in the normal pancreas and in pancreatic disease.

Authors:  Alicia K Fleming; Peter Storz
Journal:  Cell Signal       Date:  2017-08-18       Impact factor: 4.315

7.  Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice.

Authors:  S P Parihar; M Ozturk; M J Marakalala; D T Loots; R Hurdayal; D Beukes Maasdorp; M Van Reenen; D E Zak; F Darboe; A Penn-Nicholson; W A Hanekom; M Leitges; T J Scriba; R Guler; F Brombacher
Journal:  Mucosal Immunol       Date:  2017-08-09       Impact factor: 7.313

8.  CGX1037 is a novel PKC isoform delta selective inhibitor in platelets.

Authors:  Dheeraj Bhavanasi; John C Kostyak; John Swindle; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  Platelets       Date:  2014-01-16       Impact factor: 3.862

9.  Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family.

Authors:  Izumi Ohno; Guido Eibl; Irina Odinokova; Mouad Edderkaoui; Robert D Damoiseaux; Moussa Yazbec; Ravinder Abrol; William A Goddard; Osamu Yokosuka; Stephen J Pandol; Anna S Gukovskaya
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-17       Impact factor: 4.052

10.  Protein kinase C delta is essential for optimal macrophage-mediated phagosomal containment of Listeria monocytogenes.

Authors:  Anita Schwegmann; Reto Guler; Antony J Cutler; Berenice Arendse; William G C Horsnell; Alexandra Flemming; Andreas H Kottmann; Gregory Ryan; Winston Hide; Michael Leitges; Cathal Seoighe; Frank Brombacher
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.